SPRY4 and thyroid gland carcinoma: Previous functional in vitro studies developed by our group showed that siRNA-mediated SPRY4 gene silencing induced a significant decrease in TPC-1 viable cells, suggesting that this gene may have an oncogenic activity in follicular-cell-derived thyroid cancer [45].